A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients (NCT07225738)
🩺 Plain-English Summary (8th-Grade Level)
This study assesses the impact of cannabis (also commonly called marijuana, weed, or THC) use on quality of life among patients with multiple myeloma who are receiving chemotherapy. It also evaluates the potential benefits and harms of cannabis use.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (12 items) and avoid the listed exclusions (8 items).
Location: CTCA at Western Regional Medical Center — Goodyear, Arizona
Age range: 18 Years
🧪 Interventions in This Study
- Non-Interventional Study (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- \* Patients may not have completed five cycles of first line therapy or undergone any second line therapy
- Other active malignancy
- Patients may not have undergone autologous hematopoietic stem cell transplantation
- Unable to comply with the study assessments
- HCP SURVEY: Reports directly to study PI (Dr. Richard Lee)
- HCP SURVEY: Member of the study team or involved in survey design or analysis
- HCP SURVEY: Individuals with a real or perceived conflict of interest that could bias survey responses
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (11 Sites)
- CTCA at Western Regional Medical Center — Goodyear, Arizona
- City of Hope Medical Center — Duarte, California
- City of Hope Seacliff — Huntington Beach, California
- City of Hope at Irvine Lennar — Irvine, California
- City of Hope at Long Beach Elm — Long Beach, California
- City of Hope at Newport Beach Fashion Island — Newport Beach, California
- City of Hope South Pasadena — South Pasadena, California
- City of Hope Upland — Upland, California
- City of Hope West Covina — West Covina, California
- City of Hope Atlanta Cancer Center — Newnan, Georgia
- City of Hope at Chicago — Zion, Illinois
📞 Contact the Study Coordinator
Phone: (949) 671-4091
Email: RichLee@coh.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Multiple Myeloma
- Registry for Adults With Plasma Cell Disorders (PCD's) — Chapel Hill, North Carolina
- A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma — Mobile, Alabama
- A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events — San Francisco, California
- Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study) — Miami, Florida
- Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma — La Crosse, Wisconsin
Explore by condition: All Multiple Myeloma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.